Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nucleoside Analog Toxicity in HIV
NCT01386970Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- May 2005
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zidovudine, lamivudine in human immunodeficiency virus infection (HIV), sponsored by University of Colorado Denver. Started May 2005; status: completed.
02
Drugs
zidovudinelamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01386970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386970.